Written Question·Department of Health and Social Care·UIN 81298

Teplizumab

Tabled: 13 October 2025

Answered: 22 October 2025

Question

Jim Shannon

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Teplizumab in slowing the development of type 1 diabetes; and when he plans to roll-out that drug on the NHS.

Answer

Dr Zubir Ahmed

Teplizumab was licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) in August 2025, to delay the onset of Stage 3 type 1 diabetes in adult and paediatric patients 8 years of age and older with Stage 2 type 1 diabetes. Newly licensed ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 81298) →